2,6-二氯-3-氨基异烟酸甲酯 | 458543-81-2

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2,6-二氯-3-氨基异烟酸甲酯
• 中文别名: 3-氨基-2,6-二氯吡啶-4-羧酸甲酯；3-氨基-4-吡啶羧酸乙酯
• 英文名称: ethyl 3-amino-2,6-dichloroisonicotinate
• 英文别名: ethyl 3-amino-2,6-dichloropyridine-4-carboxylate
• CAS: 458543-81-2
• 化学式: C₈H₈Cl₂N₂O₂
• 分子量: 235.07
• InChiKey: ZBHSEGWPJCOBKP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  65.2
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335

反应信息

• 作为产物：
  描述：

  3-氨基吡啶-4-羧酸乙酯 在 盐酸 、 双氧水 作用下， 以 水 为溶剂， 反应 1.0h， 以36%的产率得到ethyl 3-amino-2-chloroisonicotinate
  参考文献：
  名称：

  [EN] TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS
  [FR] COMPOSÉS HÉTÉROARYLE TRICYCLIQUES UTILES EN TANT QU'INHIBITEURS D'IRAK4

  摘要：

  披露了公式(I)的化合物或其盐或前药，其中：X1和X2独立地为C或N，条件是X1和X2中零个或一个是N；环A由以下结构表示：或；以及Q、R1、R2、R3、R4、R6和p在此定义。还披露了使用此类化合物作为IRAK4调节剂的方法，以及包含此类化合物的药物组合物。这些化合物可用于治疗、预防或减缓炎性和自身免疫疾病，或用于癌症治疗。

  公开号：

  WO2021011724A1

文献信息

• Heterocyclic diamide invertebrate pest control agents
  申请人：——

  公开号：US20040102324A1

  公开（公告）日：2004-05-27

  This invention provides compounds of Formula (I), N-oxides and suitable salts thereof, wherein A and B are independently O or S; each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R 5 ; K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R 4 ; and R 1 , R 2 , R 3 , R 4 , R 5 and n are as defined in the disclosure. Also disclosed are methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula (I), an N-oxide thereof or a suitable salt of the compound (e.g., as a composition described herein). This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula (I), an N-oxide thereof or a suitable salt of the compound and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. 1

  本发明提供了式（I）的化合物、N-氧化物及其适当的盐，其中A和B分别为O或S;每个J分别为苯环、萘环系统、5-或6-成员杂环芳香环或芳香8、9或10-成员融合杂双环系统，其中每个环或环系统可选地被1到4个R5取代；K与两个相邻的连接碳原子一起，是一个5-或6-成员杂环芳香环，可选地被1到3个R4取代；以及R1、R2、R3、R4、R5和n如本公开说明中所定义的。还公开了用式（I）的化合物、其N-氧化物或化合物的适当盐（例如，如本文所述的组成物）的生物有效量接触无脊椎动物害虫或其环境的方法。本发明还涉及一种用于控制无脊椎动物害虫的组合物，包括式（I）的化合物、其N-氧化物或化合物的适当盐的生物有效量，以及至少一种来自表面活性剂、固体稀释剂和液体稀释剂的组分。
• HETEROCYCLIC DIAMIDE INVERTEBRATE PEST CONTROL AGENTS
  申请人：E. I. du Pont de Nemours and Company

  公开号：EP1373210A1

  公开（公告）日：2004-01-02
• US7560564B2
  申请人：——

  公开号：US7560564B2

  公开（公告）日：2009-07-14
• [EN] HETEROCYCLIC DIAMIDE INVERTEBRATE PEST CONTROL AGENTS<br/>[FR] AGENTS HETEROCYCLIQUES DIAMIDE DE LUTTE CONTRE DES PARASITES INVERTEBRES
  申请人：DU PONT

  公开号：WO2002070483A1

  公开（公告）日：2002-09-12

  This invention provides compounds of Formula (I), N-oxides and suitable salts thereof, wherein A and B are independently O or S; each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5; K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R?4; and R1 R2, R3, R4, R5¿ and n are as defined in the disclosure. Also disclosed are methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula (I), an N-oxide thereof or a suitable salt of the compound (e.g., as a composition described herein). This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula (I), an N-oxide thereof or a suitable salt of the compound and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.